ENBAXEB Trademark

Trademark Overview

On Tuesday, December 20, 2011, a trademark application was filed for ENBAXEB with the United States Patent and Trademark Office. The USPTO has given the ENBAXEB trademark a serial number of 85499491. The federal status of this trademark filing is ABANDONED - EXPRESS as of Thursday, February 23, 2012. This trademark is owned by Pfizer Inc.. The ENBAXEB trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of cardiovascular, central nervous system, endocrine, gastrointestinal, genetic immunological, infectious, inflammatory, menopausal, metabolic, autoimmune, musculoskeletal, neurological, ophthalmological, psychiatric, respiratory, urogenital, urological and viral diseases and disorders; pharmaceutical preparations for the treatment of erectile dysfunction, sexual dysfunction, cancer, pain and diabetes; pharmaceutical preparations for use in hematology; pharmaceutical preparations, namely, antifungal preparations, dermatological preparations, smoking cessation preparations, and tissue repair preparations; vaccines for human use; all in International Class 5
enbaxeb

General Information

Serial Number85499491
Word MarkENBAXEB
Filing DateTuesday, December 20, 2011
Status601 - ABANDONED - EXPRESS
Status DateThursday, February 23, 2012
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of cardiovascular, central nervous system, endocrine, gastrointestinal, genetic immunological, infectious, inflammatory, menopausal, metabolic, autoimmune, musculoskeletal, neurological, ophthalmological, psychiatric, respiratory, urogenital, urological and viral diseases and disorders; pharmaceutical preparations for the treatment of erectile dysfunction, sexual dysfunction, cancer, pain and diabetes; pharmaceutical preparations for use in hematology; pharmaceutical preparations, namely, antifungal preparations, dermatological preparations, smoking cessation preparations, and tissue repair preparations; vaccines for human use; all in International Class 5

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, January 3, 2012
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NamePfizer Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10017

Trademark Events

Event DateEvent Description
Thursday, February 23, 2012ABANDONMENT NOTICE MAILED - EXPRESS ABANDONMENT
Thursday, February 23, 2012ABANDONMENT - EXPRESS MAILED
Wednesday, February 22, 2012TEAS EXPRESS ABANDONMENT RECEIVED
Tuesday, January 3, 2012NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, December 23, 2011NEW APPLICATION ENTERED IN TRAM

Related Keywords

enbaxeb preparations pharmaceutical treatment dysfunction pain hematology cancer diabetes erectile disorders